You might also wanna read
Senate bill seeks to curb US reliance on China in drug industry
US lawmakers are pushing for more scrutiny of Chinese investment in pharmaceuticals and biotechnology, as Washington’s strategic competition
Senate bill seeks to curb US reliance on China in drug industry
Bipartisan US senators on Wednesday unveiled legislation aimed at increasing transparency around foreign influence in the pharmaceutical ind
STAT+: Bipartisan lawmakers want to require U.S. to probe reliance on foreign-made drugs, ingredients
A trio of bipartisan lawmakers reintroduced a bill requiring the FTC and Treasury to investigate whether the U.S. relies too heavily on fore
U.S. restrictions on Chinese biotech could harm patients, argues editorial
Patients benefit from faster, cheaper treatments, wherever they are invented
economist.com·26d agoU.S. restrictions on Chinese biotech could harm patients, argues editorial
Patients benefit from faster, cheaper treatments, wherever they are invented
The Economist·26d agoAs US lawmakers increase scrutiny of Chinese trials, industry fears ‘huge distraction and expense’
As U.S. lawmakers continue to scrutinize the consequences of China’s expanding role in biotech innovation, industry insiders have been left
U.S. restrictions on Chinese biotechnology could harm patients, argues editorial
Patients benefit from faster, cheaper treatments, wherever they are invented
econ.st·27d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.